GlassScriptPhysician profile
Swapna Kanuri
NPI 1548435803
$4,146.06
in general payments reported to CMS, 2019-2025
29 companies · $1,078 in 2025
The $1,078 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.09 · 2021: $200 · 2022: $714 · 2023: $797 · 2024: $1,344 · 2025: $1,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,218.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $756.98 | 2021-2025 | Jot Dx, Confirm Rx, Aveir |
| Novartis Pharmaceuticals Corporation | $467.95 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $304.36 | 2021-2025 | Opsumit, Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $298.33 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $249.49 | 2022-2024 | Farxiga |
| Amgen INC. | $249.45 | 2019-2025 | Repatha, Repatha |
| Daiichi Sankyo INC. | $195.60 | 2023-2024 | Injectafer |
| Esperion Therapeutics, INC. | $174.71 | 2021-2025 | Nexletol |
| Pfizer INC. | $162.13 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.10 | 2021-2025 | |
| Novo Nordisk INC | $123.66 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $115.62 | 2022-2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $110.64 | 2023-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.23 | 2022-2025 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $97.63 | 2024 | Arcalyst |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $87.47 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Scpharmaceuticals INC. | $78.71 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $66.42 | 2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $62.40 | 2025 | Amvuttra |
| Inspire Medical Systems, INC. | $49.68 | 2024-2025 | Inspire |
| Atricure, INC. | $43.51 | 2022-2024 | |
| Kiniksa Pharmaceuticals, LTD. | $42.02 | 2022-2023 | Arcalyst |
| Amarin Pharma, INC. | $40.67 | 2021-2022 | |
| Medtronic, INC. | $39.79 | 2022 | |
| Tactile Systems Technology INC | $28.93 | 2025 | Flexitouch Plus, Nimbl |
| Reflow Medical INC | $24.53 | 2025 | |
| Boston Scientific Corporation | $18.21 | 2023 | Watchman |
| Cleerly, INC. | $13.15 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Janssen Pharmaceuticals, INC | $8.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swapna Kanuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.